<p>Latest regulatory notifications, CDSCO circulars, FSSAI amendments, and compliance updates from Indian regulatory bodies.</p>
India's June 2026 narcotics enforcement surge and the DCC-approved real-time tracking portal raise the bar for pharmaceutical supply chain compliance.
Read MoreA new controlled substance under NDPS was notified in March 2026 with stock and registration deadlines in July–August 2026. Here's…
Read MoreIndia's battery and e-waste EPR framework has seen three major operational changes since February 2025. Here's what producers, importers, and…
Read MoreBIS has made FMCS applications fully digital from 1 June 2026, while a new electrical appliances QCO adds 90+ product…
Read MoreBIS adds furniture to mandatory certification, extends Scheme X deadline to September 2026, and expands CRS to 70+ electronics categories.
Read MoreIndia's cosmetic import rules are tightening in 2026. This practical guide covers COS-1 to COS-2 approval, fees, timelines, and post-approval…
Read MoreIndia's Battery Waste and E-Waste EPR frameworks have been significantly tightened for FY 2025–26 and beyond. Here's what producers and…
Read MoreIndia's PWM Amendment Rules 2026 (G.S.R. 237(E)) impose binding recycled content targets, new importer obligations, and ₹1 crore penalties. Act…
Read MoreThe March 2026 FSSAI licensing overhaul changes the rules for nutraceutical FBOs — from perpetual validity to new thresholds. Here's…
Read MoreIndia's NDPS regulatory landscape shifted significantly in late 2025 and early 2026. Here's what pharmaceutical companies must act on now.
Read More